agilon health, inc. (NYSE:AGL – Get Rating) – Investment analysts at SVB Leerink cut their Q3 2023 earnings per share estimates for shares of agilon health in a research note issued on Monday, January 9th. SVB Leerink analyst W. Mayo now expects that the company will post earnings of $0.00 per share for the quarter, down from their previous forecast of $0.01. SVB Leerink currently has a "Outperform" rating and a $30.00 target price on the stock. The consensus estimate for agilon health's current full-year earnings is ($0.21) per share. SVB Leerink also issued estimates for agilon health's FY2023 earnings at $0.08 EPS, Q1 2024 earnings at $0.13 EPS, Q2 2024 earnings at $0.09 EPS and Q3 2024 earnings at $0.06 EPS.

Several other equities research analysts have also issued reports on the company. The Goldman Sachs Group reduced their price target on agilon health from $38.00 to $34.00 and set a "buy" rating for the company in a report on Tuesday, November 15th. Royal Bank of Canada started coverage on agilon health in a report on Wednesday, September 14th. They issued an "outperform" rating and a $33.00 target price for the company. Wells Fargo & Company reduced their target price on agilon health from $28.00 to $22.00 and set an "overweight" rating for the company in a report on Tuesday, November 15th. Finally, Stifel Nicolaus started coverage on agilon health in a report on Thursday, December 8th. They issued a "buy" rating and a $23.00 target price for the company. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $28.38.

agilon health Stock Up 2.2 %

Insiders Place Their Bets

In other agilon health news, insider Benjamin Kornitzer sold 5,396 shares of agilon health stock in a transaction that occurred on Friday, October 14th. The stock was sold at an average price of $21.79, for a total value of $117,578.84. Following the transaction, the insider now directly owns 10,426 shares of the company's stock, valued at approximately $227,182.54. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other news, insider Benjamin Kornitzer sold 5,396 shares of the business's stock in a transaction that occurred on Friday, October 14th. The stock was sold at an average price of $21.79, for a total transaction of $117,578.84. Following the sale, the insider now directly owns 10,426 shares in the company, valued at $227,182.54. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Benjamin Shaker sold 29,548 shares of the business's stock in a transaction that occurred on Thursday, October 20th. The shares were sold at an average price of $20.37, for a total value of $601,892.76. Following the sale, the insider now owns 25,625 shares in the company, valued at $521,981.25. The disclosure for this sale can be found here. Insiders have sold a total of 53,834 shares of company stock valued at $1,065,775 in the last three months. Company insiders own 3.30% of the company's stock.

Institutional Trading of agilon health

A number of institutional investors and hedge funds have recently modified their holdings of the company. Bank of New York Mellon Corp increased its position in shares of agilon health by 42.9% during the third quarter. Bank of New York Mellon Corp now owns 683,463 shares of the company's stock valued at $16,006,000 after purchasing an additional 205,232 shares during the period. Captrust Financial Advisors grew its position in agilon health by 4,059.3% in the third quarter. Captrust Financial Advisors now owns 32,484 shares of the company's stock valued at $761,000 after acquiring an additional 31,703 shares during the period. Advisory Research Inc. grew its position in agilon health by 52.8% in the third quarter. Advisory Research Inc. now owns 17,814 shares of the company's stock valued at $417,000 after acquiring an additional 6,152 shares during the period. Sandia Investment Management LP bought a new stake in agilon health in the third quarter valued at $375,000. Finally, BNP Paribas Arbitrage SNC bought a new stake in agilon health in the third quarter valued at $496,000.

agilon health Company Profile

(Get Rating)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.

See Also

• Get a free copy of the StockNews.com research report on agilon health (AGL)
• Bloom Energy Powers Up After an Upgrade, is it Worth the Risk?
• Why Hershey Is a Sweet Recession Stock
• Will Amazon Stock Be Delivering for Investors in 2023?
• The Analysts Shift Trucking Sentiment Back into Forward
• The Institutions Book A Flight With Boeing

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.